PACE Trial Management Group

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

The PACE Trial Management Group is credited as an author of the PACE trial. It was responsible for the day-to-day running and management of the trial and met periodically throughout the design, implementation, and publication of the study.

Group members[edit | edit source]

Chair[edit | edit source]

  • Peter D. White, MD, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London, London, UK (Also served as a principal investigator)

Principal investigators[edit | edit source]

  • Peter D. White, MD, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London, London, UK (Also served as the PACE Trial Management Group Chair)
  • Trudie Chalder, PhD, Academic Department of Psychological Medicine, King's College London, London, UK (Also was a centre leader)
  • Michael Sharpe, MD, Psychological Medicine Research, School of Molecular and Clinical Medicine, University of Edinburgh, Edinburgh, UK

Centre leaders[edit | edit source]

  • Brian J. Angus, MD, Nuffield Department of Medicine, University of Oxford, The John Radcliffe Hospital, Oxford, UK
  • Trudie Chalder, PhD, Academic Department of Psychological Medicine, King's College London, London, UK (Also served as a principal investigator)
  • Eleanor Feldman, MRCPsyc, University of Oxford, Dept of Psychological Medicine, Barnes Unit, John Radcliffe Hospital, Headington, Oxford, UK
  • Tim Peto, RCP, Nuffield Department of Medicine, John Radcliffe Hospital, Headington, Oxford, UK
  • Michael Sharpe, MD, Psychological Medicine Research, School of Molecular and Clinical Medicine, University of Edinburgh, Edinburgh, UK (Also served as a principal investigator)
  • Peter D. White, MD, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London, London, UK (Also served as Chair and a principal investigator)
  • David Wilks, FRCP[Ed], Western General Hospital, Edinburgh, UK

Treatment leaders[edit | edit source]

  • Mary Burgess, PhD, South London and Maudsley NHS Foundation Trust, London, UK
  • Diane L. Cox, PhD, Faculty of Health and Well Being, University of Cumbria, Lancaster, UK
  • Gabrielle Murphy, MSc, Royal Free Hospital NHS Trust, London, UK (Also served as a centre leader)
  • Lucy V. Clark, PhD, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London, London, UK

Health economists[edit | edit source]

  • Paul McCrone, PhD, Centre for the Economics of Mental Health Service and Population, King's College London, London, UK

Trial statisticians[edit | edit source]

  • Rebecca Walwyn, MSc, Mental Health and Neuroscience Clinical Trials Unit, Institute of Psychiatry, King's College London, London, UK
  • Anthony L. Johnson, PhD, Medical Research Council Biostatistics Unit, Institute of Public Health, University of Cambridge, UK and Medical Research Council Clinical Trials Unit, London, UK
  • Laura Potts, MSc, Mental Health and Neuroscience Clinical Trials Unit, Institute of Psychiatry, King's College London, London, UK
  • Kimberley A. Goldsmith, MSc, MPH, Mental Health and Neuroscience Clinical Trials Unit, Institute of Psychiatry, King's College London, London, UK (Served as main statistical analyst)

Trial Managers[edit | edit source]

  • Julia C. DeCesare, MSc, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London, London, UK
  • Hannah L. Baber, MSc, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine, Queen Mary University of London, London, UK

Data Manager/Senior Research Secretary[edit | edit source]

  • Sandy Smith

Observers[edit | edit source]

PACE Trial Management Group manuscripts[edit | edit source]

References[edit | edit source]